Antizol is owned by Par Pharm Inc.
Antizol contains Fomepizole.
Antizol has a total of 1 drug patent out of which 0 drug patents have expired.
Antizol was authorised for market use on 04 December, 1997.
Antizol is available in injectable;injection dosage forms.
The generics of Antizol are possible to be released after 30 June, 2027.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.|
|US7553863||PAR PHARM INC||Ultrapure 4-methylpyrazole|| |
(4 years from now)
Drugs and Companies using FOMEPIZOLE ingredient
Market Authorisation Date: 04 December, 1997
Korea, Republic of
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic